18F-Fdg And 68Ga-Dotatate Pet/Ct In Von Hippel-Lindau Disease-Associated Retinal Hemangioblastoma
Abstract
Retinal hemangioblastomas are highly vascular benign tumors that can be encountered either sporadically or within the von Hippel-Lindau (VHL) syndrome. We report a case of a VHL patient with retinal hemangioblastoma who underwent PET/CT scans using F-FDG and Ga-DOTATATE. The tumor showed low-level F-FDG and increased Ga-DOTATATE activity, suggesting cell-surface overexpression of somatostatin receptors. The presented case indicates the clinical applications of somatostatin receptor imaging with Ga-DOTA-conjugated peptides in detection and follow-up of VHL manifestations, screening of asymptomatic gene carriers, and in diagnosis of sporadic retinal hemangioblastomas, which may have similar features on MRI with other retinal tumors.
Publication Date
3-1-2017
Publication Title
Clinical nuclear medicine
Volume
42
Issue
3
Number of Pages
189-190
Document Type
Article
Personal Identifier
scopus
DOI Link
https://doi.org/10.1097/RLU.0000000000001511
Copyright Status
Unknown
Socpus ID
85028254527 (Scopus)
Source API URL
https://api.elsevier.com/content/abstract/scopus_id/85028254527
STARS Citation
Papadakis, Georgios Z.; Millo, Corina; Jassel, Inderbir S.; Bagci, Ulas; and Sadowski, Samira M., "18F-Fdg And 68Ga-Dotatate Pet/Ct In Von Hippel-Lindau Disease-Associated Retinal Hemangioblastoma" (2017). Scopus Export 2015-2019. 5429.
https://stars.library.ucf.edu/scopus2015/5429